Watchtower/Law library/Money Laundering, Terrorist.../37 Application of simplified...
As last captured

Money Laundering, Terrorist Financing and Transfer of Funds... · CHAPTER 3 Simplified customer due diligence

37 Application of simplified customer due diligence

reg. 37 · in force: yes

Captured statutory text (L5)

37 Application of simplified customer due diligence

(1)A relevant person may apply simplified customer due diligence measures in relation to a particular business relationship or transaction if it determines that the business relationship or transaction presents a low degree of risk of money laundering and terrorist financing, having taken into account—
(a)the risk assessment it carried out under regulation 18(1);
(b)relevant information made available to it under regulations 17(9) and 47; and
(c)the risk factors referred to in paragraph (3).
(2)Where a relevant person applies simplified customer due diligence measures, it must—
(a)continue to comply with the requirements in regulations 28 , 29 and 30A, but it may adjust the extent, timing or type of the measures it undertakes under regulations 28 and 29(11) to (13) to reflect its determination under paragraph (1); and
(b)carry out sufficient monitoring of any business relationships or transactions which are subject to those measures to enable it to detect any unusual or suspicious transactions.
(3)When assessing whether there is a low degree of risk of money laundering and terrorist financing in a particular situation, and the extent to which it is appropriate to apply simplified customer due diligence measures in that situation, the relevant person must take account of risk factors including, among other things—
(a)customer risk factors, including whether the customer—
(i)is a public administration, or a publicly owned enterprise;
(ii)is an individual resident in a geographical area of lower risk (see sub-paragraph (c));
(iii)is a credit institution or a financial institution which is—
(aa)subject to requirements in national legislation having an equivalent effect to those laid down in the fourth money laundering directive on an obliged entity (within the meaning of that directive); and
(bb)supervised for compliance with those requirements in a manner equivalent to section 2 of Chapter VI of the fourth money laundering directive;
(iv)is a company whose securities are listed on a regulated market, and the location of the regulated market;
(b)product, service, transaction or delivery channel risk factors, including whether the product or service is—
(i)a life insurance policy for which the premium is low;
(ii)an insurance policy for a pension scheme which does not provide for an early surrender option, and cannot be used as collateral;
(iii)a pension, superannuation or similar scheme which satisfies the following conditions—
(aa)the scheme provides retirement benefits to employees;
(bb)contributions to the scheme are made by way of deductions from wages; and
(cc)the scheme rules do not permit the assignment of a member's interest under the scheme;
(iv)a financial product or service that provides appropriately defined and limited services to certain types of customers to increase access for financial inclusion purposes in the United Kingdom;
(v)a product where the risks of money laundering and terrorist financing are managed by other factors such as purse limits or transparency of ownership;
(vi)a child trust fund within the meaning given by section 1(2) of the Child Trust Funds Act 2004 ;
(vii)a junior ISA within the meaning given by regulation 2B of the Individual Savings Account Regulations 1998 ;
(c)geographical risk factors, including whether the country where the customer is resident, established or registered or in which it operates is—
(i)the United Kingdom;
(ii)a third country which has effective systems to counter money laundering and terrorist financing;
(iii)a third country identified by credible sources as having a low level of corruption or other criminal activity, such as terrorism (within the meaning of section 1 of the Terrorism Act 2000 ), money laundering, and the production and supply of illicit drugs;
(iv)a third country which, on the basis of credible sources, such as evaluations, detailed assessment reports or published follow-up reports published by the Financial Action Task Force, the International Monetary Fund, the World Bank, the Organisation for Economic Co-operation and Development or other international bodies or non-governmental organisations—
(aa)has requirements to counter money laundering and terrorist financing that are consistent with the revised Recommendations published by the Financial Action Task Force in February 2012 and updated in October 2016; and
(bb)effectively implements those Recommendations.
(4)In making the assessment referred to in paragraph (3), relevant persons must bear in mind that the presence of one or more risk factors may not always indicate that there is a low risk of money laundering and terrorist financing in a particular situation.
(5)A relevant person may apply simplified customer due diligence measures where the customer is a person to whom paragraph (6) applies and the product is an account into which monies are pooled (the “pooled account”), provided that—
(a)the business relationship with the holder of the pooled account presents a low degree of risk of money laundering and terrorist financing; and
(b)information on the identity of the persons on whose behalf monies are held in the pooled account is available, on request to the relevant person where the pooled account is held.
(6)This paragraph applies to—
(a)a relevant person who is subject to these Regulations under regulation 8;
(b)a person who carries on business in a third country who is—
(i)subject to requirements in national legislation having an equivalent effect to those laid down in the fourth money laundering directive on an obliged entity (within the meaning of that directive); and
(ii)supervised for compliance with those requirements in a manner equivalent to section 2 of Chapter VI of the fourth money laundering directive.
(7). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(8)A relevant person must not continue to apply simplified customer due diligence measures under paragraph (1)—
(a)if it doubts the veracity or accuracy of any documents or information previously obtained for the purposes of identification or verification;
(b)if its risk assessment changes and it no longer considers that there is a low degree of risk of money laundering and terrorist financing;
(c)if it suspects money laundering or terrorist financing; or
(d)if any of the conditions set out in regulation 33(1) apply.
Full captured verbatim text
(1) A relevant person may apply simplified customer due diligence measures in relation to a particular business relationship or transaction if it determines that the business relationship or transaction presents a low degree of risk of money laundering and terrorist financing, having taken into account—

(a) the risk assessment it carried out under regulation 18(1);

(b) relevant information made available to it under regulations 17(9) and 47; and

(c) the risk factors referred to in paragraph (3).

(2) Where a relevant person applies simplified customer due diligence measures, it must—

(a) continue to comply with the requirements in regulations 28 , 29 and 30A, but it may adjust the extent, timing or type of the measures it undertakes under regulations 28 and 29(11) to (13) to reflect its determination under paragraph (1); and

(b) carry out sufficient monitoring of any business relationships or transactions which are subject to those measures to enable it to detect any unusual or suspicious transactions.

(3) When assessing whether there is a low degree of risk of money laundering and terrorist financing in a particular situation, and the extent to which it is appropriate to apply simplified customer due diligence measures in that situation, the relevant person must take account of risk factors including, among other things—

(a) customer risk factors, including whether the customer—

(i) is a public administration, or a publicly owned enterprise;

(ii) is an individual resident in a geographical area of lower risk (see sub-paragraph (c));

(iii) is a credit institution or a financial institution which is—

(aa) subject to requirements in national legislation having an equivalent effect to those laid down in the fourth money laundering directive on an obliged entity (within the meaning of that directive); and

(bb) supervised for compliance with those requirements in a manner equivalent to section 2 of Chapter VI of the fourth money laundering directive;

(iv) is a company whose securities are listed on a regulated market, and the location of the regulated market;

(b) product, service, transaction or delivery channel risk factors, including whether the product or service is—

(i) a life insurance policy for which the premium is low;

(ii) an insurance policy for a pension scheme which does not provide for an early surrender option, and cannot be used as collateral;

(iii) a pension, superannuation or similar scheme which satisfies the following conditions—

(aa) the scheme provides retirement benefits to employees;

(bb) contributions to the scheme are made by way of deductions from wages; and

(cc) the scheme rules do not permit the assignment of a member's interest under the scheme;

(iv) a financial product or service that provides appropriately defined and limited services to certain types of customers to increase access for financial inclusion purposes in the United Kingdom;

(v) a product where the risks of money laundering and terrorist financing are managed by other factors such as purse limits or transparency of ownership;

(vi) a child trust fund within the meaning given by section 1(2) of the Child Trust Funds Act 2004 ;

(vii) a junior ISA within the meaning given by regulation 2B of the Individual Savings Account Regulations 1998 ;

(c) geographical risk factors, including whether the country where the customer is resident, established or registered or in which it operates is—

(i) the United Kingdom;

(ii) a third country which has effective systems to counter money laundering and terrorist financing;

(iii) a third country identified by credible sources as having a low level of corruption or other criminal activity, such as terrorism (within the meaning of section 1 of the Terrorism Act 2000 ), money laundering, and the production and supply of illicit drugs;

(iv) a third country which, on the basis of credible sources, such as evaluations, detailed assessment reports or published follow-up reports published by the Financial Action Task Force, the International Monetary Fund, the World Bank, the Organisation for Economic Co-operation and Development or other international bodies or non-governmental organisations—

(aa) has requirements to counter money laundering and terrorist financing that are consistent with the revised Recommendations published by the Financial Action Task Force in February 2012 and updated in October 2016; and

(bb) effectively implements those Recommendations.

(4) In making the assessment referred to in paragraph (3), relevant persons must bear in mind that the presence of one or more risk factors may not always indicate that there is a low risk of money laundering and terrorist financing in a particular situation.

(5) A relevant person may apply simplified customer due diligence measures where the customer is a person to whom paragraph (6) applies and the product is an account into which monies are pooled (the “pooled account”), provided that—

(a) the business relationship with the holder of the pooled account presents a low degree of risk of money laundering and terrorist financing; and

(b) information on the identity of the persons on whose behalf monies are held in the pooled account is available, on request to the relevant person where the pooled account is held.

(6) This paragraph applies to—

(a) a relevant person who is subject to these Regulations under regulation 8;

(b) a person who carries on business in a third country who is—

(i) subject to requirements in national legislation having an equivalent effect to those laid down in the fourth money laundering directive on an obliged entity (within the meaning of that directive); and

(ii) supervised for compliance with those requirements in a manner equivalent to section 2 of Chapter VI of the fourth money laundering directive.

(7) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(8) A relevant person must not continue to apply simplified customer due diligence measures under paragraph (1)—

(a) if it doubts the veracity or accuracy of any documents or information previously obtained for the purposes of identification or verification;

(b) if its risk assessment changes and it no longer considers that there is a low degree of risk of money laundering and terrorist financing;

(c) if it suspects money laundering or terrorist financing; or

(d) if any of the conditions set out in regulation 33(1) apply.

What this provision means

Model summary, checked against the text on the left.

Relevance to Signicat: 2/3 · detailed summary (L4) Status: failed · Stored artifact; current recipe verification unavailable

Relevant persons may apply simplified customer due diligence upon determining low risk, subject to mandatory monitoring and cessation triggers.

Only the one-line summary above is stored for this provision; the text itself is the evidence.

Refers to

other law external_cite · s. 1

cross-reference internal_cite · reg. 17

cross-reference internal_cite · reg. 18

cross-reference internal_cite · reg. 28

cross-reference internal_cite · reg. 29

cross-reference internal_cite · reg. 33

cross-reference internal_cite · reg. 47

cross-reference internal_cite · reg. 8

Referred to by

cross-reference internal_cite · reg. 19

cross-reference internal_cite · reg. 3

cross-reference internal_cite · reg. 38

cross-reference internal_cite · reg. 40

cross-reference internal_cite · Sch. 6 para. 7

Part summaries

0 of 0 parts have a verified summary.

L1 unavailable for current verification: the overall summary needs every part verified. Provisions and the verified summaries remain readable.

Verification findings (348)

synthesis coverage: missing/unverified L2 part-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-4

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-5

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-6

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-7

synthesis coverage: missing/unverified L2 part-2-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-8

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-9

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-10

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-11

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-12

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-13

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-14

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-14A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-15

synthesis coverage: missing/unverified L2 part-2-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-16

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-16A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-17

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-18

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-18A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-19

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-19A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-20

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-21

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-22

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-23

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-24

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-25

synthesis coverage: missing/unverified L2 part-2-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-26

synthesis coverage: missing/unverified L2 part-3-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-27

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-28

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-29

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-30

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-30ZA

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-30A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-31

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-32

synthesis coverage: missing/unverified L2 part-3-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-33

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-34

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-35

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-36

synthesis coverage: missing/unverified L2 part-3-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-37

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-38

synthesis coverage: missing/unverified L2 part-4

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-39

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-40

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-41

synthesis coverage: missing/unverified L2 part-5

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-42

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-43

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-44

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45ZA

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45ZB

synthesis coverage: missing/unverified L2 part-5A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45B

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45C

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45D

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45E

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45F

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45G

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45H

synthesis coverage: missing/unverified L2 part-6-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-46

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-46A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-47

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-48

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-49

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-50

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-51

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-52

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-52A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-52B

synthesis coverage: missing/unverified L2 part-6-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-53

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-54

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-55

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-56

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-56A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-56B

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-57

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-58

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-58A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-59

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-60

synthesis coverage: missing/unverified L2 part-6-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-60A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-60B

synthesis coverage: missing/unverified L2 part-7

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-61

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-62

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-63

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64

synthesis coverage: missing/unverified L2 part-7A-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64B

synthesis coverage: missing/unverified L2 part-7A-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64C

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64D

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64E

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64F

synthesis coverage: missing/unverified L2 part-7A-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64G

synthesis coverage: missing/unverified L2 part-7A-chapter-4

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64H

synthesis coverage: missing/unverified L2 part-8

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-65

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-66

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-67

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-68

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-69

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-70

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-71

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-72

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-73

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-74

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-74A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-74B

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-74C

synthesis coverage: missing/unverified L2 part-9-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-75

synthesis coverage: missing/unverified L2 part-9-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-76

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-77

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-78

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-79

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-80

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-81

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-82

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-83

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-84

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-85

synthesis coverage: missing/unverified L2 part-9-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-86

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-87

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-88

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-89

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-90

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-91

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-92

synthesis coverage: missing/unverified L2 part-10-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-93

synthesis coverage: missing/unverified L2 part-10-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-94

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-95

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-96

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-97

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-98

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-99

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-100

synthesis coverage: missing/unverified L2 part-11

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-101

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-102

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-103

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-104

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-104A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-105

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-106

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-107

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-108

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-109

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-110

synthesis coverage: missing/unverified L2 schedule-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-27

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-27A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-29

synthesis coverage: missing/unverified L2 schedule-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-30

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-31

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-32

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-33

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-34

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-35

synthesis coverage: missing/unverified L2 schedule-3AZA

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3AZA-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3AZA-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3AZA-paragraph-3

synthesis coverage: missing/unverified L2 schedule-3A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-1A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-6A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-8A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-9A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-9B

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-23A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-24

synthesis coverage: missing/unverified L2 schedule-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-12A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-15A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-19

synthesis coverage: missing/unverified L2 schedule-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-5-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-5-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-5-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-5-paragraph-4

synthesis coverage: missing/unverified L2 schedule-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-9A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-11A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-13

synthesis coverage: missing/unverified L2 schedule-6A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-16

synthesis coverage: missing/unverified L2 schedule-6B

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-5

synthesis coverage: missing/unverified L2 schedule-7-part-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-11

synthesis coverage: missing/unverified L2 schedule-7-part-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-27

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-29

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-30

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-31

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-32

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-33

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-34

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-35

Instrument tier unavailable

Change history as published

Reg. 22 omitted (31.12.2020) by virtue of The Money Laundering and Transfer of Funds (Information) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/253), regs. 1(2), 5(4) (with savings in S.I. 2019/680, reg. 11); 2020 c. 1, Sch. 5 para. 1(1)

Pt. 5A omitted (1.9.2022) by virtue of The Money Laundering and Terrorist Financing (Amendment) (No. 2) Regulations 2022 (S.I. 2022/860), regs. 1(5), 10 · repeated 8×

Sch. 7 para. 27 revoked (24.2.2025) by The Procurement Act 2023 (Consequential and Other Amendments) Regulations 2025 (S.I. 2025/163), reg. 1(2), Sch. Pt. 2

Pending effects amendments not yet applied to this text

reg. 3(1) words inserted by The Money Laundering and Transfer of Funds (Information) (Amendment) (EU Exit) Regulations 2019 reg. 3(b) · Effective date unknown · reg. 3

reg. 34A inserted by The Money Laundering and Terrorist Financing (Amendment) Regulations 2026 reg. 20 · Effective date unknown

Sch. 6 para. 7(ga) inserted by The Money Laundering and Terrorist Financing (Amendment) Regulations 2026 reg. 36(b) · Effective date unknown · Sch. 6 para. 7

Provenance

Every claim the system makes about this text is traceable to these identifiers.

Instrument
uk:uksi/2017/692
Part
CHAPTER 3 Simplified customer due diligence
Version
c5a0271554697d8359bede8a…
Content hash
sha256 9a9dbf235cf551baf4374dcc…
Source
legislation.gov.uk/uksi/2017/692